Malignant neoplasm of corpus uteri, including Hilmo

C3_CORPUS_UTERI_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C54 Hospital discharge: ICD-9 — 182 Hospital discharge: ICD-8 — 1820 Cause of death: ICD-10 — C54 Cause of death: ICD-9 — 182 Cause of death: ICD-8 — 1820 Cancer registry: Topography ICD-O-3 — C54 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	3753
4. Check minimum number of events None	3753
5. Include endpoints None	3753
6. Filter based on genotype QC (FinnGen only)	3636

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_CORPUS_UTERI_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C54
HD_ICD_9	182
HD_ICD_8	1820
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C54
COD_ICD_9	182
COD_ICD_8	1820
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C54
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of corpus uteri, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of corpus uteri

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3636	3636	-
Unadjusted period prevalence (%)	1.29	1.29	-
Median age at first event (years)	65.41	65.41	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3753: Matched controls
37528

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JAL31

NOMESCO Finland

Laparoscopic omentectomy

145.9

308.3

154

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

31.0

307.7

244

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

4503599627370496.0

307.7

1950

115

Kela drug reimbursment

Breast cancer

+∞

307.7

346

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

307.7

850

ZXC96

NOMESCO Finland

Robot assisted procedure

75.6

307.7

620

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

97.3

307.7

1348

215

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

17.8

307.7

757

524

XX3DW

NOMESCO Finland

Time consuming IT work

10.3

307.7

759

902

A04AA02

ATC

granisetron; systemic, transdermal

198.5

307.7

276

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

1864.8

307.7

328

B01AB05

ATC

enoxaparin; parenteral

3.7

307.7

1999

8761

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

17.7

307.7

510

331

WF003

NOMESCO Finland

Adjuvant radiotherapy

1340.5

307.7

752

L03AA13

ATC

pegfilgrastim; parenteral

3933.5

307.7

367

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

10.4

307.7

747

874

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

4.6

307.7

2075

7981

128

Kela drug reimbursment

Cancers of female genital organs

6936.3

307.7

1041

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

211.0

307.7

274

PJA12

NOMESCO Finland

Sentinel node biopsy

694.8

307.7

319

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

4763.6

307.7

434

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

7.0

307.7

1149

2226

N85.1

ICD-10 Finland

Endometrial adenomatous hyperplasia

21.4

307.7

392

203

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

307.7

2933

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

7097.2

307.7

609

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

67.3

307.7

210

WF002

NOMESCO Finland

Radical radiotherapy

70.7

307.7

251

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

45.7

307.7

224

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

4750.9

307.7

433

LCA06

NOMESCO Finland

Biopsy of endometrium

5.6

307.7

1358

3430

H02AB02

ATC

dexamethasone; systemic

57.1

307.7

886

202

A03FA01

ATC

metoclopramide; systemic, rectal

5.6

307.7

1340

3386

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

307.7

701

N95.0

ICD-10 Finland

Postmenopausal bleeding

10.5

307.7

1851

3173

JN4BD

NOMESCO Finland

Extensive body CT

13.9

307.7

849

773

L02AB02

ATC

medroxyprogesterone; systemic

41.7

307.7

220

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

9.8

307.7

663

802

LCD00

NOMESCO Finland

Hysterectomy

7.2

307.7

739

1231

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

6.0

307.7

1192

2698

L02BG04

ATC

letrozole; oral

137.9

307.7

428

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

67.0

307.7

285

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

307.7

461

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

115.4

307.7

176

JN4AD

NOMESCO Finland

Body CT examination

10.5

307.7

770

902

B01AB10

ATC

tinzaparin; parenteral

13.2

307.7

1373

1576

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

36.3

307.7

2059

1216

A04AA01

ATC

ondansetron; systemic, rectal

12.2

307.7

632

614

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

409.9

306.6

304

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

2972.6

299.8

286

JAL30

NOMESCO Finland

Omentectomy

30.1

285.0

189

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

597.9

283.7

278

WX302

NOMESCO Finland

Thoracal epidural anesthesy

10.2

283.4

331

352

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

283.0

268

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

4.6

281.9

805

2121

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

279.7

265

HAB40

NOMESCO Finland

Wedge excision of mammary gland

22.1

272.5

203

Z51.5

ICD-10 Finland

Palliative care

6.9

268.5

442

708

WZC00

NOMESCO Finland

Treatment plan or consultation

3.3

268.3

1655

7274

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

260.5

247

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

247.7

235

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

25.8

243.1

170

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2356.7

242.2

232

WX402

NOMESCO Finland

General anaesthesia

3.6

236.3

1013

3520

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

236.0

224

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

234.9

223

A04AA55

ATC

palonosetron, combinations; systemic

+∞

227.4

216

N84.0

ICD-10 Finland

Polyp of corpus uteri

3.9

225.8

800

2441

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

7.9

223.8

321

440

HA1AA

NOMESCO Finland

X-ray mammography

5.9

217.7

420

784

8380/2-C54.1

ICD-O-3

Endometrioid intraepithelial neoplasia of endometrium

45.7

217.0

128

LEB00

NOMESCO Finland

Biopsy of vagina

9.1

216.6

275

325

130

Kela drug reimbursment

Malignant tumour

+∞

215.7

205

WF049

NOMESCO Finland

Radiotherapy of metastasis

556.4

214.3

211

ULC02

NOMESCO Finland

Hysteroscopy

4.7

214.0

553

1331

TPH07

NOMESCO Finland

Cathetrisation of artery

4.0

195.5

648

1875

L02BA01

ATC

tamoxifen; oral

337.4

193.4

194

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.1

189.4

1000

3889

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

189.2

180

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

183.9

175

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

182.8

174

L03AA14

ATC

lipegfilgrastim; parenteral

1944.2

182.7

176

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

176.5

168

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

174.3

166

WW500

NOMESCO Finland

Blood transfusion

8.5

172.2

228

283

WF099

NOMESCO Finland

Other radiotherapy

48.9

172.1

100

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

171.2

163

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

9.6

168.9

202

220

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.1

166.1

305

540

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

1587.0

154.2

149

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

66.1

152.9

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

151.1

144

JN4CD

NOMESCO Finland

Very extensive body CT

9.1

149.6

186

213

HAC20

NOMESCO Finland

Total mastectomy

223.1

146.1

150

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

145.8

139

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

143.7

137

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

137.3

131

D70.82

ICD-10 Finland

Drug-induced neutropenia

29.1

136.3

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

207.7

135.7

140

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

4.4

132.0

358

884

C50.99

ICD-10 Finland

Breast, unspecified

655.3

129.3

127

C54.13

ICD-10 Finland

Clear cell carcinoma of the endometrium

+∞

128.9

123

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

3.7

127.1

441

1299

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

1270.3

126.8

123

ZX090

NOMESCO Finland

Other technic of radiotherapy

224.3

126.6

130

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1259.6

125.8

122

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

169.6

125.2

131

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

6.9

124.8

197

298

L03AA02

ATC

filgrastim; parenteral

165.6

122.1

128

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

50.2

119.3

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

118.3

113

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

55.1

114.5

ZXE20

NOMESCO Finland

More than three and less than five hours

2.9

112.7

625

2435

X77

ICPC

Malignant neopl genital female other

1121.2

112.1

109

D07.0

ICD-10 Finland

Carcinoma in situ: Endometrium

167.9

108.9

114

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

284.4

108.5

110

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

24.3

104.0

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

103.6

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

+∞

101.5

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

265.1

101.3

103

Z31.5

ICD-10 Finland

Genetic counselling

5.0

100.5

223

466

C54

ICD-10 Finland

Malignant neoplasm of corpus uteri

+∞

100.5

WZC30

NOMESCO Finland

Teaching

2.8

99.6

592

2382

C54.23

ICD-10 Finland

Carcinosarcoma

+∞

99.4

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

99.4

JAL00

NOMESCO Finland

Biopsy of peritoneum

24.6

98.8

ZX070

NOMESCO Finland

Intensity modified radiotherapy

254.1

97.1

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

32.6

94.6

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.3

94.0

106

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

43.7

93.8

LCD30

NOMESCO Finland

Radical hysterectomy

199.1

93.8

ZX120

NOMESCO Finland

Intravenous

3.3

92.9

386

1268

ZX080

NOMESCO Finland

Image guided radiotherapy

469.1

92.7

C54.0

ICD-10 Finland

Malignant neoplasm: Isthmus uteri

+∞

91.0

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

5.1

90.7

196

400

C54.2

ICD-10 Finland

Malignant neoplasm: Myometrium

+∞

89.9

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

7.5

88.6

129

178

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

87.8

WF004

NOMESCO Finland

Palliative radiotherapy

442.8

87.5

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.2

87.5

247

625

LCA10

NOMESCO Finland

Curettage of body of uterus

4.4

87.1

229

549

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

86.8

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.6

86.7

560

2340

L01BC06

ATC

capecitabine; oral

+∞

85.7

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

25.4

85.7

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.7

84.8

108

127

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

84.6

1496

9408

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

836.7

83.9

C54.22

ICD-10 Finland

Endometrial stromal cell sarcoma

+∞

82.6

N02AA05

ATC

oxycodone; systemic

2.3

82.4

783

3891

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

3.7

80.8

273

784

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

805.4

80.7

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

10.2

79.8

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

79.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.1

78.7

138

232

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

78.4

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

78.4

Z51.0

ICD-10 Finland

Radiotherapy session

774.1

77.6

ZZR00

NOMESCO Finland

Flap of skin

14.2

76.7

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

76.3

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

+∞

74.2

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

9.5

73.8

C50

ICD-10 Finland

Malignant neoplasm of breast

255.1

73.6

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

73.3

946

5272

A79

ICPC

Malignancy NOS

115.3

73.1

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

100.9

72.1

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

13.0

70.9

L02BG03

ATC

anastrozole; oral

+∞

70.0

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

6.4

69.6

116

185

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

69.0

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

67.5

399

1585

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

65.8

A04AD12

ATC

aprepitant; systemic

332.8

65.7

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

3.4

65.3

246

757

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

64.8

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

63.7

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

63.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

61.9

459

2030

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

61.6

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

4.1

60.9

172

434

18200

ICD-8 Finland

Other malignant neoplasm of uterus, Carcinoma corporis uteri

+∞

60.6

X76

ICPC

Malignant neoplasm breast female

108.5

59.0

B02AA02

ATC

tranexamic acid; systemic

2.1

59.0

697

3726

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

8.7

59.0

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

58.5

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

203.2

58.2

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

57.4

8310/3-C54.1

ICD-O-3

Clear cell adenocarcinoma, NOS, of endometrium

+∞

57.4

ZXC40

NOMESCO Finland

Use of ultrasound

12.3

57.4

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.0

55.8

123

255

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

147.2

55.0

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

54.3

C54.29

ICD-10 Finland

Unspecified uterine sarcoma

+∞

54.3

8140/3-C54.1

ICD-O-3

Adenocarcinoma, NOS, of endometrium

+∞

53.2

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

53.0

369

1581

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

525.2

52.6

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

52.2

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.4

51.9

190

573

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

51.2

L02BG06

ATC

exemestane; oral

+∞

51.2

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

50.9

412

1887

JEA00

NOMESCO Finland

Appendectomy

3.0

50.2

233

811

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.5

49.9

179

533

8980/3-C54.1

ICD-O-3

Carcinosarcoma, NOS, of endometrium

+∞

49.1

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

484.0

48.5

XX2RW, ,

NOMESCO Finland

10.3

48.4

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

4.2

48.2

131

321

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

48.2

1755

13017

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

48.0

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

48.0

X12

ICPC

Postmenopausal bleeding

6.1

47.4

136

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.3

46.6

JAH01

NOMESCO Finland

Laparoscopy

3.2

46.5

194

634

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

463.4

46.4

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

463.4

46.4

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

14.8

45.9

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

45.9

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

45.9

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

10.3

45.8

N02BE01

ATC

paracetamol; systemic, rectal

2.4

45.8

3478

31455

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

453.1

45.3

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

158.6

44.9

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

44.9

LC003

NOMESCO Finland

Adjuvant radiotherapy of uterus and uterine ligaments

+∞

44.9

C56

ICD-10 Finland

Malignant neoplasm of ovary

442.9

44.3

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

12.4

43.6

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.9

43.6

216

779

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

43.3

442

2219

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

42.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.6

41.9

139

393

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.4

41.8

157

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

41.7

8890/3-C54.9

ICD-O-3

Leiomyosarcoma, NOS, of corpus uteri

+∞

41.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

13.6

41.7

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

13.7

40.8

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

401.8

40.2

KA1FN

NOMESCO Finland

Isotope renography

10.1

39.8

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

39.7

125

341

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

39.6

R18

ICD-10 Finland

Ascites

5.6

39.5

136

A04AA03

ATC

tropisetron; systemic

65.0

39.1

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

87.0

38.8

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

138.1

38.8

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

56.9

38.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

37.6

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

37.6

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

36.5

KCD02

NOMESCO Finland

Transurethral resection of bladder

10.9

36.4

WZC15, ,

NOMESCO Finland

54.3

36.4

B01AB04

ATC

dalteparin; parenteral

2.5

35.7

234

971

JAH00

NOMESCO Finland

Laparotomy

3.7

35.6

116

324

JFF23

NOMESCO Finland

Transversostomy

11.3

34.5

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

34.4

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

34.4

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

340.2

34.0

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

176.6

33.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

33.6

382

1988

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

33.4

182

8310

FHL

Radical hysterectomy (includes lymph node removal)

+∞

33.4

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

33.4

8890/3-C54.2

ICD-O-3

Leiomyosarcoma, NOS, of myometrium

+∞

33.4

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.6

33.3

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

8.4

33.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

32.8

240

1047

A06AH03

ATC

naloxegol; oral

7.2

32.6

ZX112

NOMESCO Finland

Subcutaneous

6.4

32.5

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

32.3

C54.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of corpus uteri

+∞

32.3

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

32.3

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

32.3

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

32.3

Z85.4

ICD-10 Finland

Personal history of malignant neoplasm of genital organs

319.7

31.9

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

43.7

31.8

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

31.8

118

359

ULA02

NOMESCO Finland

Kolposcopy

2.0

31.0

383

2050

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

5.5

30.3

106

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

30.2

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

30.2

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

30.2

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

58.8

30.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

29.9

431

2428

JFB00

NOMESCO Finland

Partial resection of small intestine

4.4

29.4

167

R50.9

ICD-10 Finland

Fever, unspecified

1.9

29.3

437

2488

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

29.2

G03DA02

ATC

medroxyprogesterone; systemic

1.7

28.8

582

3621

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

28.7

233

1063

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

28.2

C54.20

ICD-10 Finland

Malignant tumor of the myometrium without histology

+∞

28.2

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

146.1

27.7

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

146.1

27.7

Z3232

NOMESCO Finland

Midwife

2.7

27.2

148

560

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

7.4

27.1

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

27.1

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

27.1

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

27.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.2

27.1

110

XX1AD

NOMESCO Finland

Other CT-examination

75.7

26.8

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

37.0

26.1

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

26.1

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

+∞

26.1

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

262.4

25.7

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

33.3

25.5

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

25.2

191

846

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

25.0

S18

ICPC

Laceration/cut

1.4

24.8

1598

12780

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

21.4

24.7

XX1XN

NOMESCO Finland

Other isotope examination

251.8

24.7

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

20.2

24.3

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.3

24.1

2050

8931/3-C54.1

ICD-O-3

Endometrial stromal sarcoma, low grade of endometrium

+∞

24.0

K62.7

ICD-10 Finland

Radiation proctitis

+∞

24.0

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

25.6

23.9

N85.9

ICD-10 Finland

Noninflammatory disorder of uterus, unspecified

4.2

23.8

156

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

23.8

166

709

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

87.3

23.7

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

241.5

23.7

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

125.8

23.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

23.5

461

2836

R2110

NOMESCO Finland

Giving the first information

2.0

23.4

272

1423

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

33.6

23.3

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

23.3

113

403

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

54.4

23.0

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

22.9

3019

Kela drug reimbursment

Lenvatinib

+∞

22.9

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

22.9

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

22.9

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

7.1

22.9

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

84.0

22.7

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

40.3

22.6

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

8.2

22.6

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.2

22.6

145

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.1

22.3

L01EX08

ATC

lenvatinib; oral

+∞

21.9

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

21.9

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

21.9

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

21.9

WX704

NOMESCO Finland

Intubation

2.0

21.6

258

1362

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

20.8

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

20.8

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

20.8

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.4

20.8

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

20.7

266

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

0.1

20.6

1228

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

211.1

20.6

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.6

20.4

184

N81.1

ICD-10 Finland

Cystocele

0.5

20.2

150

3140

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.6

20.2

181

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

20.0

688

4831

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

4.5

19.8

108

X75

ICPC

Malignant neoplasm cervix

+∞

19.8

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

19.8

1XA02, ,

NOMESCO Finland

+∞

19.8

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

19.8

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

105.6

19.6

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

105.6

19.6

N02AX02

ATC

tramadol; systemic, rectal

1.4

19.4

1492

12136

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.3

19.3

143

628

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

0.2

19.2

1199

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.6

19.2

115

458

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

18.3

19.1

G03AC03

ATC

levonorgestrel; oral, implant

0.5

18.9

155

3134

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.0

18.8

198

1000

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

15.9

18.8

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

15.9

18.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

18.8

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

18.8

1508

Kela drug reimbursment

Lenvatinib

+∞

18.8

L02BA03

ATC

fulvestrant; parenteral

+∞

18.8

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

18.8

159

Kela drug reimbursment

Pazopanib

+∞

18.8

N30.4

ICD-10 Finland

Irradiation cystitis

70.2

18.7

B03XA02

ATC

darbepoetin alfa; parenteral

3.7

18.7

162

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

100.6

18.6

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

100.6

18.6

3AA13, ,

NOMESCO Finland

190.9

18.5

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

38.6

18.5

K56.7

ICD-10 Finland

Ileus, unspecified

3.5

18.4

183

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.1

18.4

243

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

18.1

348

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

18.1

895

6737

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

5.0

17.8

21899

ICD-8 Finland

Uterine fibroma

0.4

17.7

2023

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

17.7

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

17.7

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

17.7

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

17.7

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

17.7

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

17.7

Z70.8

ICD-10 Finland

Other sex counselling

14.6

17.6

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

180.8

17.5

B29

ICPC

Lymph/immune mech sympt/complt other

7.4

17.4

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

0.4

17.2

104

2358

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.5

17.2

167

LCA96

NOMESCO Finland

Other intrauterine operation

3.9

17.1

130

Z3231

NOMESCO Finland

Registered nurse

1.4

17.0

866

6541

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.9

17.0

131

JN6AD

NOMESCO Finland

CT of torso and neck

5.6

16.9

N93

ICD-10 Finland

Other abnormal uterine and vaginal bleeding

7.2

16.9

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

16.9

192

996

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

16.7

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

16.7

8980/3-C54.9

ICD-O-3

Carcinosarcoma, NOS, of corpus uteri

+∞

16.7

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

16.7

C53.09

ICD-10 Finland

Malignant tumor of endocervix, unspecified histology

+∞

16.7

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

16.7

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

16.7

ZX121

NOMESCO Finland

Central venous catheter

35.2

16.7

JFB30

NOMESCO Finland

Right hemicolectomy

5.5

16.6

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

170.7

16.5

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

20.1

16.4

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.7

16.4

315

1922

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

40.2

16.3

R4190

NOMESCO Finland

Nutritional therapy

2.8

16.3

305

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.3

16.3

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

16.2

147

702

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.9

16.1

257

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

13.6

16.0

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.1

16.0

160

794

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.9

15.9

264

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

15.9

132

609

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

15.7

171

3155

SPAT1153

SPAT

Removal of sutures

1.4

15.7

1079

8550

TPX15

NOMESCO Finland

Removal of vascular injection port

15.7

LWA00

NOMESCO Finland

Repair of wound dehiscence in gynaecological surgery

12.9

15.6

8323/3-C54.1

ICD-O-3

Mixed cell adenocarcinoma of endometrium

+∞

15.6

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

+∞

15.6

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

15.6

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

15.6

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

15.6

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

15.6

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

15.6

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

15.6

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

15.6

149

726

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.0

15.5

160

803

LCA98

NOMESCO Finland

Other transluminal endoscopic operation on uterus

3.8

15.5

126

N84.1

ICD-10 Finland

Polyp of cervix uteri

2.2

15.4

137

649

XLD10

NOMESCO Finland

Gynaecological examination

4.8

15.4

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

15.4

235

1343

KA3EB

NOMESCO Finland

Antegrade pyelography

12.4

15.3

UKC02

NOMESCO Finland

Cystoscopy

1.6

15.3

403

2658

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

2.8

15.2

265

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

5.5

15.2

N81.6

ICD-10 Finland

Rectocele

0.5

15.1

161

2990

T90

ICPC

Diabetes non-insulin dependent

1.4

14.9

850

6523

J01DB01

ATC

cefalexin; oral

1.4

14.9

2860

26250

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

14.9

689

9076

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

31.8

14.8

E66.8

ICD-10 Finland

Other obesity

1.9

14.6

176

932

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

14.6

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

14.6

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

14.6

L01CA04

ATC

vinorelbine; systemic

+∞

14.6

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

14.6

HAC25

NOMESCO Finland

Radical mastectomy

+∞

14.6

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

14.6

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

14.6

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

14.6

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

150.6

14.5

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

150.6

14.5

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

14.5

265

1595

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

5.4

14.5

A46

ICD-10 Finland

Erysipelas

1.5

14.3

484

3370

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

14.3

254

1516

KBV10

NOMESCO Finland

Removal of stent from ureter

5.5

14.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

14.1

2265

20157

N85.7

ICD-10 Finland

Haematometra

6.4

14.1

UJF32

NOMESCO Finland

Coloscopy

1.4

14.0

938

7383

TJF80

NOMESCO Finland

Ostomy education

5.7

13.7

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.6

13.6

378

2521

R31

ICD-10 Finland

Unspecified haematuria

1.8

13.6

221

1286

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

13.5

1CD02, ,

NOMESCO Finland

+∞

13.5

192

Kela drug reimbursment

Fulvestrant

+∞

13.5

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

+∞

13.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

13.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

13.5

8930/3-C54.1

ICD-O-3

Endometrial stromal sarcoma, NOS, of endometrium

+∞

13.5

8461/3-C54.1

ICD-O-3

High grade serous carcinoma of endometrium

+∞

13.5

18220, ,

ICD-8 Finland

+∞

13.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

13.5

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

+∞

13.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

13.5

X81

ICPC

Genital neopl female other/unspecif

16.2

13.4

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

25.8

13.4

A10BA02

ATC

metformin; oral

1.3

13.3

989

7892

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.9

13.3

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

40.2

13.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

13.1

1279

10613

LAE21

NOMESCO Finland

Bilateral laparoscopic oophorectomy

5.2

12.9

D75

ICPC

Malignant neoplasm colon/rectum

19.1

12.9

SPAT1125

SPAT

Stoma care and guidance

2.6

12.9

284

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

14.1

12.7

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

12.7

135

685

LEE00

NOMESCO Finland

Suture of vagina

10.5

12.7

WX400

NOMESCO Finland

Inhalation anesthesy

2.1

12.5

123

607

L01CB01

ATC

etoposide; systemic

+∞

12.5

C53.99

ICD-10 Finland

Malignant tumor in unspecified localization in cervix, unspecified histology

+∞

12.5

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

12.5

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

12.5

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

12.5

1CD01, ,

NOMESCO Finland

+∞

12.5

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

9.3

12.5

TQW20

NOMESCO Finland

Tatoe

20.1

12.4

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

12.2

274

1738

A08

ICPC

Swelling

1.7

12.2

215

1280

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

12.2

878

6963

5703

FHL

Removal of lymph nodes from the retroperitoneal space

26.8

12.0

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

11.9

3110

29210

KAC10

NOMESCO Finland

Total nephrectomy with capsule

13.4

11.9

X14

ICPC

Vaginal discharge

2.8

11.9

209

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.6

11.9

272

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

46.8

11.9

U06

ICPC

Haematuria

2.6

11.8

267

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.9

11.8

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

11.7

11.8

JFF10

NOMESCO Finland

Loop enterostomy

11.7

11.8

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

16.4

11.6

HA1SA

NOMESCO Finland

Expansion mammography

16.4

11.6

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

11.6

175

996

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

4.0

11.6

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

65.1

11.6

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

65.1

11.6

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

65.1

11.6

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.5

11.6

108

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.7

11.5

390

5471

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.8

11.5

161

896

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.3

11.5

C03CA01

ATC

furosemide; systemic

1.3

11.5

1228

10267

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

11.5

108

525

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

11.5

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

11.5

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

11.5

343

Kela drug reimbursment

Pazopanib

+∞

11.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

11.5

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

11.5

1501

Kela drug reimbursment

Palbociclib

+∞

11.5

394

Kela drug reimbursment

Palbociclib

+∞

11.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

11.5

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

11.5

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

11.5

8010/3-C54.1

ICD-O-3

Carcinoma, NOS, of endometrium

+∞

11.5

C53

ICD-10 Finland

Malignant neoplasm of cervix uteri

120.4

11.4

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.1

11.4

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

11.8

11.3

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.1

11.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

11.2

154

853

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

4.7

11.2

Y60.0

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation

4.6

11.2

ZX050

NOMESCO Finland

Stereotactic radiotherapy

12.7

11.1

P01AB01

ATC

metronidazole; oral, rectal

1.3

11.1

1435

12275

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

10.0

11.0

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

0.5

10.9

1648

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

43.4

10.9

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

10.8

447

3230

S77

ICPC

Malignant neoplasm of skin

12.9

10.6

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

60.2

10.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.5

10.6

252

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

8.5

10.5

R03DC03

ATC

montelukast; oral

0.7

10.5

316

4540

SPAT1088

SPAT

Blood transfusion

4.8

10.5

8305

FHL

Supravaginal amputation or resection

0.2

10.5

650

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

10.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

10.4

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

10.4

1820C

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]

+∞

10.4

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

10.4

PJW99

NOMESCO Finland

Other operation on lymphatic system

+∞

10.4

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

10.4

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

10.4

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

10.4

L01AX03

ATC

temozolomide; systemic

+∞

10.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

10.4

L01XE11

ATC

[U] pazopanib

+∞

10.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

10.4

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

10.4

8140/3-C54.9

ICD-O-3

Adenocarcinoma, NOS, of corpus uteri

+∞

10.4

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

10.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

10.4

C90.0

ICD-10 Finland

Multiple myeloma

+∞

10.4

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

10.4

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

10.4

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.8

10.3

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

10.3

813

6515

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.8

10.2

181

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.5

10.2

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

2.3

10.2

306

8308

FHL

Hysterectomy and bilateral adnexal removal

1.9

10.1

126

677

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

0.5

10.1

1667

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

10.0

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

40.2

10.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

9.9

284

G02BA03

ATC

plastic IUD with progestogen

0.5

9.8

1636

M05BA02

ATC

clodronic acid; systemic

20.1

9.8

JG1BG

NOMESCO Finland

MRI of rectum

20.1

9.8

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

20.1

9.8

A02BC02

ATC

pantoprazole; systemic

1.3

9.7

2446

22455

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.0

9.7

137

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.6

1025

8529

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

7.8

9.6

D39.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other female genital organs

7.8

9.6

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

9.6

900

7368

L57.0

ICD-10 Finland

Actinic keratosis

1.5

9.5

333

2332

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.7

9.4

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

100.3

9.4

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

100.3

9.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

100.3

9.4

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

100.3

9.4

YX9AW, ,

NOMESCO Finland

100.3

9.4

C53.12

ICD-10 Finland

Adenocarcinoma of the exocervix

100.3

9.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

100.3

9.4

KKA10

NOMESCO Finland

Biopsy of retroperitoneal tissue

100.3

9.4

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

100.3

9.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

30.1

9.4

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

9.4

1510

Kela drug reimbursment

Niraparib

+∞

9.4

18221, ,

ICD-8 Finland

+∞

9.4

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

9.4

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

9.4

L01XK02

ATC

niraparib; oral

+∞

9.4

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

9.4

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

9.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

9.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

9.4

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

9.4

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

9.4

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

9.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

9.4

1800A

ICD-9 Finland

Malignant neoplasm of cervix uteri, Endocervix

+∞

9.4

3009

Kela drug reimbursment

Niraparib

+∞

9.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

9.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

9.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

9.3

236

1543

T88.9

ICD-10 Finland

Complication of surgical and medical care, unspecified

4.7

9.3

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

10.7

9.3

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

9.5

9.3

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

7.3

9.2

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

7.3

9.2

DHB00

NOMESCO Finland

Excision of lesion of external nose

7.3

9.2

K65.0

ICD-10 Finland

Acute peritonitis

3.2

9.2

115

LWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gynaecological surgery

11.5

9.1

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

15.6

9.0

D77

ICPC

Malignant digestive neopl other/NOS

36.8

9.0

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

24.1

8.9

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.8

8.9

131

743

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

3.9

8.9

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

8.8

332

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.6

8.8

190

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

9.5

8.8

TQB05

NOMESCO Finland

Puncture of skin of trunk

9.5

8.8

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

8.7

158

950

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

50.1

8.7

OAA41

NOMESCO Finland

Health check based on individual needs

50.1

8.7

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

8.7

277

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.3

8.6

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

8.6

266

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

16.3

8.5

G03DB01

ATC

dydrogesterone; oral

1.4

8.5

464

3509

I89.8

ICD-10 Finland

Other specified noninfective disorders of lymphatic vessels and lymph nodes

27.6

8.5

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

20.1

8.5

N63

ICD-10 Finland

Unspecified lump in breast

1.6

8.4

184

1162

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

90.3

8.4

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

90.3

8.4

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

90.3

8.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

90.3

8.4

FM1FN

NOMESCO Finland

Heart function isotope examination

90.3

8.4

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.1

8.4

106

N82.0

ICD-10 Finland

Vesicovaginal fistula

12.8

8.4

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

4.5

8.4

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.9

8.4

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

+∞

8.3

LFD10

NOMESCO Finland

Vulvectomy and excision of regional lymph nodes

+∞

8.3

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

8.3

L01EF01

ATC

palbociclib; oral

+∞

8.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

8.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

8.3

8020/3-C54.1

ICD-O-3

Carcinoma, undifferentiated, NOS, of endometrium

+∞

8.3

C78.5

ICD-10 Finland

Secondary malignant neoplasm of large intestine and rectum

+∞

8.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

8.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

8.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

8.3

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

8.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

8.3

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

8.3

8931/3-C54.2

ICD-O-3

Endometrial stromal sarcoma, low grade of myometrium

+∞

8.3

8980/3-C54.2

ICD-O-3

Carcinosarcoma, NOS, of myometrium

+∞

8.3

OAB39

NOMESCO Finland

Sexual health guidance

+∞

8.3

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

8.3

ZX100

NOMESCO Finland

Oral

2.9

8.3

133

HAE99

NOMESCO Finland

Other reconstruction of breast

10.8

8.3

SPAT1262

SPAT

Handing over of treatment supplies

1.3

8.2

559

4371

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

8.2

193

1240

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

2.1

8.2

383

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

0.6

8.1

160

2521

J45

ICD-10 Finland

Asthma

0.6

8.1

178

2737

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

8.1

117

660

R03AC02

ATC

salbutamol; inhalant

0.8

8.1

1534

17187

JFA80

NOMESCO Finland

Suture of colon

11.7

8.1

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

11.7

8.1

6170A

ICD-9 Finland

Endometriosis of uterus

0.2

8.0

351

R60.0

ICD-10 Finland

Localized oedema

1.4

8.0

466

3559

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

8.0

167

1042

JFB46

NOMESCO Finland

Resection of sigmoid colon

2.9

8.0

125

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.9

8.0

125

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.7

8.0

321

4382

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.4

7.9

225

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.4

7.9

225

WX234

NOMESCO Finland

Paracervical blockade

2.6

7.8

166

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

2.7

7.8

149

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.5

7.8

178

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

7.8

447

3407

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

4.1

7.8

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

45.1

7.7

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

45.1

7.7

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

45.1

7.7

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.8

7.7

626

7712

N71.1

ICD-10 Finland

Chronic inflammatory disease of uterus

5.9

7.7

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.0

7.6

112

J45.1

ICD-10 Finland

Nonallergic asthma

0.6

7.6

108

1846

TJA10

NOMESCO Finland

Laparocentesis

18.4

7.6

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

18.4

7.6

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

8.0

7.6

A21

ICPC

Risk factor for malignancy

25.0

7.6

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

25.0

7.6

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.9

7.5

113

R03BA01

ATC

beclometasone; inhalant

0.7

7.5

293

4025

C10AA07

ATC

rosuvastatin; oral

0.8

7.5

869

10274

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

7.4

257

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

80.3

7.4

LEB10

NOMESCO Finland

Excision of lesion of vagina

3.4

7.4

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

7.6

7.4

LAE20

NOMESCO Finland

Bilateral oophorectomy

3.3

7.4

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

7.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

7.3

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

7.3

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

7.3

18201

ICD-8 Finland

Other malignant neoplasm of uterus, Carcinoma corporis et cervicis uteri

+∞

7.3

18202

ICD-8 Finland

Other malignant neoplasm of uterus, Sarcoma uteri

+∞

7.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

7.3

8000/3-C54.9

ICD-O-3

Neoplasm, malignant of corpus uteri

+∞

7.3

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

7.3

C54.3

ICD-10 Finland

Malignant neoplasm: Fundus uteri

+∞

7.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

7.3

1XC07, ,

NOMESCO Finland

+∞

7.3

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

7.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.3

C79.1

ICD-10 Finland

Secondary malignant neoplasm of bladder and other and unspecified urinary organs

+∞

7.3

WC205

NOMESCO Finland

Simple therapy of local tumor recidive with hormone

+∞

7.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

7.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

7.3

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

7.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.3

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

7.3

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

+∞

7.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

7.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

7.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

7.3

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

7.2

106

603

R01AD09

ATC

mometasone; nasal

0.8

7.2

1127

12921

LCB98

NOMESCO Finland

Other transluminal endoscopic excision of lesion of uterus

2.7

7.2

133

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

7.2

484

3780

L04AX03

ATC

methotrexate; systemic

0.6

7.2

171

2579

GDC00

NOMESCO Finland

Lobectomy of lung

30.1

7.1

KCD10

NOMESCO Finland

Partial cystectomy

30.1

7.1

C10AX09

ATC

ezetimibe; oral

0.7

7.1

309

4171

JFA70

NOMESCO Finland

Suture of small intestine

6.6

7.1

Z93.3

ICD-10 Finland

Colostomy status

5.6

7.1

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

8.8

7.0

A10BJ06

ATC

semaglutide; parenteral

1.7

7.0

133

812

R03BB04

ATC

tiotropium bromide; inhalant

0.6

7.0

131

2084

Z2221

NOMESCO Finland

Medical doctor

1.2

6.9

811

6787

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.5

6.8

172

M03BX02

ATC

tizanidine; oral

0.8

6.8

1713

18821

HA1HA

NOMESCO Finland

Tomosynthesis mammography

8.3

6.8

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

6.1

6.8

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

40.1

6.8

J01MA12

ATC

levofloxacin; systemic

1.3

6.7

498

3937

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

22.5

6.7

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

22.5

6.7

M04AA01

ATC

allopurinol; systemic

1.4

6.6

308

2270

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

6.6

J45.9

ICD-10 Finland

Asthma, unspecified

0.8

6.6

451

5696

JAD10

NOMESCO Finland

Repair of incisional hernia

3.0

6.6

KBH20

NOMESCO Finland

Replantation of ureter

7.8

6.6

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

7.8

6.6

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.4

6.6

175

LEC00

NOMESCO Finland

Partial excision of vagina

12.3

6.6

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

6.6

498

3950

SPAT1255

SPAT

Intravenous administration of medicine

1.5

6.6

196

1331

N05CB02

ATC

barbiturates in combination with other drugs

1.6

6.6

133

827

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

6.5

474

5940

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

6.5

136

2114

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

6.5

123

750

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

6.5

137

859

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.8

6.5

LDA00

NOMESCO Finland

Dilatation of cervix uteri

2.7

6.5

123

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.5

6.5

1292

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

0.4

6.5

738

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.2

6.5

227

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

6.5

557

4491

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

70.0

6.4

R96

ICPC

Asthma

0.7

6.4

202

2883

LCD10

NOMESCO Finland

Vaginal hysterectomy

0.5

6.4

1037

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

3.6

6.3

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.3

6.3

K56.0

ICD-10 Finland

Paralytic ileus

2.9

6.3

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

+∞

6.2

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

6.2

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

6.2

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

6.2

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

6.2

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

6.2

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

6.2

L02BA02

ATC

toremifene; oral

+∞

6.2

C53.0

ICD-10 Finland

Malignant neoplasm: Endocervix

+∞

6.2

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

6.2

L01EF02

ATC

ribociclib; oral

+∞

6.2

C53.1

ICD-10 Finland

Malignant neoplasm: Exocervix

+∞

6.2

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

6.2

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

6.2

8930/3-C54.2

ICD-O-3

Endometrial stromal sarcoma, NOS, of myometrium

+∞

6.2

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

6.2

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

+∞

6.2

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

6.2

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

6.2

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

6.2

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

6.2

9706

FHL

Ablation mammae, includes axillary exploration

+∞

6.2

8010/3-C54.9

ICD-O-3

Carcinoma, NOS, of corpus uteri

+∞

6.2

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

6.2

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

6.2

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

6.2

8890/3-C55.9

ICD-O-3

Leiomyosarcoma, NOS, of uterus, NOS

+∞

6.2

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

6.2

D05.0

ICD-10 Finland

Lobular carcinoma in situ

+∞

6.2

1514, ,

Kela drug reimbursment

+∞

6.2

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

6.2

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

6.2

3002

Kela drug reimbursment

Ribociclib

+∞

6.2

L01XE33

ATC

[U] palbociclib

+∞

6.2

L01EX03

ATC

pazopanib; oral

+∞

6.2

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

6.2

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

6.2

C53.10

ICD-10 Finland

Malignant tumor of the exocervix without histology

+∞

6.2

8480/3-C54.1

ICD-O-3

Mucinous adenocarcinoma of endometrium

+∞

6.2

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

+∞

6.2

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

6.2

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

6.2

Z80.9

ICD-10 Finland

Family history of malignant neoplasm, unspecified

26.7

6.2

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

26.7

6.2

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

26.7

6.2

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.0

6.2

339

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

6.2

114

692

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

6.2

394

5024

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.5

6.2

156

JG1CG

NOMESCO Finland

Extensive MRI of rectum

7.7

6.1

SPAT1229

SPAT

Assessment of need for aid

1.4

6.1

319

2399

5702

FHL

Local lymph node removal (eg armpit, groin)

12.5

6.1

J01MA02

ATC

ciprofloxacin; systemic

1.2

6.0

1223

10790

G03FB06

ATC

medroxyprogesterone and estrogen; systemic

1.3

6.0

529

4275

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

6.0

299

2230

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2496

13096

3.70

316.34

2.7

2.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1795

1591

20.71

307.65

4.7

1.5

45.83

24.75

u/ml

1.81

1766

1497

(4281824) Cell count and differential, peritoneal fluid

902

194

60.89

307.65

1.1

—

(4035726) Immunohistochemistry procedure

1000

757

17.64

307.65

1.6

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

740

694

13.04

307.65

1.3

1.4

190.91

73.79

pmol/l

5.71

730

675

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

247

158

16.66

289.71

1.0

1.2

—

(40768804) Tissue Pathology biopsy report

2085

10787

3.10

249.55

2.6

1.7

—

(40768795) Lymph node Pathology biopsy report

147

34.73

232.07

1.1

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

1765

8701

2.94

223.89

2.3

2.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2312

13814

2.75

192.68

4.2

3.5

34.79

35.63

g/l

9.94

2199

12475

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

574

1775

3.64

155.18

3.1

1.4

5.39

2.68

ug/l

1.33

452

1321

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

660

2246

3.35

153.50

1.6

2.0

0.22

0.21

g/l

7.00

635

2030

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1332

6621

2.57

153.02

2.3

2.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

118

18.43

147.17

2.3

1.1

26.38

15.43

u/ml

2.65

108

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1218

6238

2.41

126.72

1.4

1.3

—

(3002256) Pathology report gross observation

620

2279

3.06

124.97

1.3

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2273

15236

2.25

122.21

6.5

3.5

10.29

10.67

umol/l

0.69

2165

14056

(3003694) ABO and Rh group [Type] in Blood

1230

6535

2.31

115.70

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

649

2560

2.86

114.45

4.5

6.4

118.80

119.20

g/l

0.21

637

2476

(3003396) Base excess in Arterial blood by calculation

744

3200

2.65

110.59

4.5

5.8

1.16

1.65

mmol/l

3.07

593

2548

(3012095) Magnesium [Moles/volume] in Serum or Plasma

932

4484

2.43

109.11

3.8

2.1

0.80

0.82

mmol/l

6.87

874

4022

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

741

3215

2.63

107.98

4.5

5.8

5.28

5.09

kpa

6.19

715

3041

(3027801) Oxygen [Partial pressure] in Arterial blood

739

3212

2.62

107.24

4.5

5.8

13.61

11.70

kpa

15.35

714

3035

(3013650) Neutrophils [#/volume] in Blood by Automated count

2315

16606

2.03

91.96

11.0

6.3

4.00

4.17

e9/l

2.34

2018

14116

(3023368) Bacteria identified in Blood by Culture

1291

7540

2.09

91.41

4.2

3.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

480

1894

2.76

83.02

5.6

6.3

25.00

mmol/l

0.01

465

1795

(3016502) Oxygen saturation in Arterial blood

625

2825

2.45

81.68

4.5

6.1

97.06

95.28

19.68

607

2699

(3019060) Gas panel - Arterial blood

484

1990

2.64

76.91

3.4

4.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

419

1618

2.79

75.22

4.8

6.9

94.99

93.35

10.87

419

1613

(40768793) Breast Pathology biopsy report

132

238

5.71

69.97

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1160

7129

1.91

66.69

3.3

3.2

94.79

91.83

3.69

1134

6916

(3015377) Calcium [Moles/volume] in Serum or Plasma

1660

11422

1.81

66.33

3.4

2.1

2.37

mmol/l

0.11

1462

9432

(3020891) Body temperature

332

1229

2.87

64.20

3.8

4.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2379

18591

1.76

58.05

4.4

3.9

6.90

6.71

mmol/l

3.83

2279

17215

(3022217) INR in Platelet poor plasma by Coagulation assay

2000

14931

1.73

57.03

14.6

16.7

1.20

1.27

inr

3.08

600

4107

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

24.62

54.98

1.5

1.0

10.18

1.55

ug/l

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2230

17269

1.72

54.58

5.9

5.1

1.20

1.23

mmol/l

31.02

1849

14463

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2919

24498

1.86

53.05

8.0

5.3

84.76

76.28

u/l

10.03

2758

22424

(40758558) Short blood count panel - Blood

1097

7069

1.78

51.57

8.4

4.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2032

15536

1.67

50.39

5.2

4.7

1.20

1.22

mmol/l

26.29

1851

13665

(3031040) Bacteria [#/volume] in Urine by Automated count

2705

22683

1.69

43.48

6.1

5.3

1037.73

3361.32

e6/l

3.09

295

(3009261) Glucose [Presence] in Urine by Test strip

2119

16840

1.59

41.19

4.8

4.4

0.00

estimate

1.08

399

2778

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

40.69

1.1

0.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

2098

16690

1.58

40.15

6.0

5.9

0.00

estimate

0.50

398

2736

(3026008) Bacteria identified in Urine by Culture

1745

13327

1.58

39.68

4.1

3.6

—

(3000991) Gas panel - Venous blood

428

2231

2.04

37.66

4.9

6.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

550

3128

1.89

37.50

3.6

3.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

202

819

2.55

32.34

2.6

3.1

0.36

0.40

u/ml

0.99

110

494

(3014111) Lactate [Moles/volume] in Serum or Plasma

437

2429

1.90

31.67

4.5

5.0

1.21

1.37

mmol/l

2.91

428

2364

(3042936) Bacteria identified in Isolate by Culture

601

3775

1.70

28.74

2.1

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

165

660

2.57

27.17

2.7

1.8

108.91

16.49

u/ml

2.00

134

525

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

225

1038

2.24

26.95

2.1

1.7

4.28

2.07

ug/l

0.87

194

873

(3020779) Urea [Moles/volume] in Serum or Plasma

394

2239

1.85

26.45

6.0

5.6

9.59

10.35

mmol/l

1.11

371

2095

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

460

2745

1.77

26.25

3.8

2.6

249.67

242.78

u/l

0.53

431

2536

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

406

2349

1.82

25.69

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

700

4693

1.60

25.65

8.0

7.0

—

(3002582) Erythrocytes [#/volume] in Urine

1218

9261

1.47

24.68

3.3

3.2

65.00

78.05

e6/l

0.26

922

6875

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1197

9073

1.47

24.64

4.0

2.5

31.33

31.18

u/l

0.05

1142

8453

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

8.63

23.64

2.4

1.2

138.33

72.93

ng/l

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

142

568

2.56

23.40

1.5

2.3

4.17

3.48

g/l

4.39

137

538

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

108

375

2.94

23.36

2.3

1.9

88.09

20.77

u/ml

1.23

335

(3018095) Leukocytes [#/volume] in Urine

1417

11219

1.42

22.58

4.0

3.7

219.67

143.08

e6/l

1.04

1004

7531

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

262

1373

1.98

22.41

5.5

8.0

—

(3018418) pH of Serum or Plasma

1322

10348

1.43

22.40

3.4

3.1

7.40

0.54

271

1713

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

125

481

2.65

22.29

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.99

21.66

2.9

3.6

—

(3029937) Albumin [Presence] in Urine by Test strip

1172

9027

1.43

21.50

5.6

4.9

0.00

estimate

0.50

389

2768

(3007853) Bacteria identified in Skin by Aerobe culture

525

3434

1.61

20.96

1.8

—

(36304419) Bacteria [Presence] in Urine

1099

8413

1.43

20.69

3.1

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

1127

8669

1.43

20.65

3.0

3.1

0.58

0.47

e6/l

0.63

850

6490

(3000850) Epithelial cells [#/volume] in Urine

875

6538

1.44

18.43

2.7

2.6

7.99

7.22

e6/l

0.57

771

5782

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3360

31514

1.63

18.39

18.0

13.3

31.04

21.03

mg/l

37.99

2871

24524

(40761535) Cells panel - Urine sediment

464

3049

1.60

18.03

4.1

3.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

908

6876

1.42

17.66

2.9

2.3

2.49

2.47

mmol/l

7.05

815

5871

(3003458) Phosphate [Moles/volume] in Serum or Plasma

551

3787

1.53

17.54

4.5

4.1

1.04

mmol/l

0.08

498

3404

(3018572) Chloride [Moles/volume] in Blood

143

655

2.23

17.47

3.8

6.7

105.65

104.06

mmol/l

4.36

133

580

(3039000) Anion gap in Blood

143

655

2.23

17.47

3.8

6.7

10.89

11.16

mmol/l

0.43

133

580

(3049717) Cytology report of Urine Cyto stain

157

750

2.14

17.28

2.3

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

13.27

16.92

1.1

—

(3044889) 12 lead EKG panel

2568

23018

1.37

16.77

4.3

4.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

234

1303

1.85

16.64

3.5

4.7

1.70

1.57

1.07

221

1217

(3020630) Protein [Mass/volume] in Serum or Plasma

404

2631

1.60

16.23

3.5

1.5

65.96

66.58

g/l

1.01

365

2287

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

381

2463

1.61

15.77

3.5

2.4

59.08

61.30

ml/min/173m2

0.67

166

1013

(3015736) pH of Urine

1599

13448

1.33

15.62

4.5

4.1

5.45

5.93

5.23

605

(3026782) Osmolality of Urine

819

6219

1.41

15.38

3.0

491.00

496.81

mosm/kgh2o

0.36

698

5234

(3035350) Ketones [Presence] in Urine by Test strip

1929

16690

1.32

15.30

5.0

4.4

0.00

estimate

1.71

438

3072

(3007930) Methemoglobin/Hemoglobin.total in Blood

227

1293

1.80

15.01

3.6

4.7

0.88

0.89

0.09

214

1209

(3017181) Myelocytes/100 leukocytes in Blood

373

2433

1.59

14.85

3.2

3.6

1.33

0.77

2.77

152

577

(3021589) Normoblasts [#/volume] in Blood

1584

13440

1.31

14.01

11.2

8.5

0.00

e9/l

0.22

1298

10926

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

132

643

2.09

13.87

1.5

1.9

93.44

93.33

0.02

127

603

(40760892) CBC W Ordered Manual Differential panel - Blood

1643

14034

1.30

13.74

5.6

5.7

—

(40761536) Microorganisms panel - Urine sediment

382

2579

1.54

13.03

5.5

4.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2543

23120

1.31

12.84

5.5

5.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

126

623

2.06

12.75

1.6

2.2

228.00

186.89

5.12

120

589

(3036489) Thrombin time

171

946

1.85

12.46

1.5

1.7

21.04

21.27

0.20

154

821

(3011397) Hemoglobin [Presence] in Urine by Test strip

1036

8430

1.32

11.98

4.5

4.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1485

12674

1.28

11.95

5.5

4.8

—

(40768806) Pleura Pathology biopsy report

150

3.16

11.91

1.3

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

595

4451

1.40

11.89

1.9

29.10

29.52

0.94

576

4281

(3027945) Reticulocytes/100 erythrocytes in Blood

461

3303

1.45

11.70

2.8

2.1

1.90

1.84

0.54

397

2836

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

5.53

11.63

5.7

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

403

2820

1.48

11.55

3.3

2.9

1.24

mmol/l

0.23

349

2303

(3047181) Lactate [Moles/volume] in Blood

168

951

1.80

11.39

3.9

5.8

1.20

1.31

mmol/l

0.79

154

838

(3021440) Promyelocytes/100 leukocytes in Blood

343

2351

1.51

10.87

3.2

3.7

0.25

0.06

3.62

122

498

(3002179) Metamyelocytes/100 leukocytes in Blood

332

2267

1.51

10.71

3.0

3.4

0.82

0.57

1.47

118

521

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1217

10239

1.28

10.65

2.8

2.2

55.65

58.20

u/l

0.67

1116

9222

(3019550) Sodium [Moles/volume] in Serum or Plasma

3482

33503

1.54

10.61

22.0

16.0

139.45

139.78

mmol/l

10.05

3429

32508

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

265

1728

1.57

10.54

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

537

4037

1.39

10.33

2.3

2.4

18.92

20.88

2.78

438

3295

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

870

7066

1.30

9.90

1.5

1.7

1.86

1.19

mg/l

3.47

690

5395

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

128

697

1.87

9.87

1.8

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

225

1437

1.60

9.79

3.2

2.6

0.21

0.32

e6/l

1.26

218

1385

(3009214) Lutropin [Units/volume] in Serum or Plasma

163

2.84

9.79

1.2

25.02

21.34

u/l

0.63

121

(3023103) Potassium [Moles/volume] in Serum or Plasma

3482

33573

1.51

9.71

22.0

16.1

3.96

mmol/l

0.03

3425

32513

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

4.19

9.62

1.7

1.1

0.49

2.41

ug/l

2.40

(3004789) Transferrin [Mass/volume] in Serum or Plasma

566

4341

1.36

9.57

2.2

2.3

2.28

2.39

g/l

3.64

508

3923

(40757494) Bilirubin.total [Moles/volume] in Blood

155

2.86

9.47

1.8

1.9

18.76

14.26

umol/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

687

5441

1.32

9.33

2.7

2.6

1.74

1.52

e6/l

0.50

381

3072

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

617

4825

1.33

9.14

2.9

2.8

4.93

5.22

e6/l

0.16

316

2470

(3021447) Carbon dioxide [Partial pressure] in Venous blood

394

2867

1.42

9.13

2.9

3.2

5.74

5.87

kpa

1.70

381

2790

(3022948) Iron [Moles/volume] in Serum or Plasma

609

4785

1.33

8.70

2.3

10.97

12.32

umol/l

4.77

553

4341

(3004809) Band form neutrophils/100 leukocytes in Blood

348

2.15

8.65

2.1

2.9

2.01

0.97

1.20

296

(3019198) Lymphocytes [#/volume] in Blood

1746

15559

1.23

8.64

5.3

5.4

1.72

1.86

e9/l

2.68

1500

13538

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

636

5043

1.31

8.50

1.7

1.8

—

(3025159) Blasts/100 leukocytes in Blood

319

2267

1.44

8.42

3.2

3.7

0.06

0.09

0.33

434

(3024354) Oxygen [Partial pressure] in Venous blood

338

2432

1.43

8.34

2.7

2.8

4.43

kpa

0.00

326

2363

(3006315) Basophils [#/volume] in Blood

1704

15192

1.22

8.25

5.2

5.4

0.04

e9/l

4.81

1438

12923

(3001604) Monocytes [#/volume] in Blood

1697

15136

1.22

8.15

5.2

5.4

0.56

0.57

e9/l

1.13

1433

12891

(40761511) CBC panel - Blood by Automated count

3376

32511

1.38

8.01

18.5

13.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

218

2.40

7.98

2.7

1.8

1276.61

1730.60

u/l

0.12

(3002032) Base excess in Venous blood by calculation

386

2865

1.39

7.96

3.0

3.2

2.24

2.22

mmol/l

0.02

322

2485

(3013115) Eosinophils [#/volume] in Blood

1751

15708

1.21

7.81

5.4

5.5

0.17

0.19

e9/l

7.00

1494

13570

(3025130) Human papilloma virus identified in Specimen

390

2.02

7.80

1.4

1.7

—

(3019150) Specific gravity of Urine by Refractometry

919

7708

1.25

7.80

5.7

5.0

1.01

1.02

kg/l

0.30

103

1220

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1264

10984

1.23

7.72

2.9

3.0

1656.52

1387.72

ng/l

0.82

1092

9410

(3023520) Reticulocytes [#/volume] in Blood

339

2475

1.41

7.71

3.0

2.1

73.03

70.93

e9/l

0.42

251

1850

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

189

2.45

7.40

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2027

18511

1.21

7.31

3.4

2.9

51.75

42.07

u/l

4.19

1855

16688

(3002030) Lymphocytes/100 leukocytes in Blood

1605

14358

1.21

7.15

5.4

5.7

25.39

28.17

16.45

1493

13201

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3130

29926

1.28

7.00

18.1

12.3

73.74

73.92

ml/min/173m2

0.19

2724

23782

(3003434) Protein [Mass/volume] in Pleural fluid

240

2.23

6.88

1.3

1.4

33.04

27.11

g/l

2.61

200

(3019069) Monocytes/100 leukocytes in Blood

1568

14054

1.20

6.70

5.4

5.9

8.52

8.47

0.21

1457

12889

(3027273) Bicarbonate [Moles/volume] in Venous blood

228

1606

1.45

6.35

2.9

3.0

25.45

25.59

mmol/l

0.24

223

1563

(3012544) pH of Venous blood

384

2954

1.33

6.30

2.9

3.2

7.37

7.42

—

(40758358) Immune stain study

+∞

6.25

1.0

0.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

6.25

1.0

0.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

199

2.28

6.21

1.3

1.4

45395.75

51324.12

e6/l

0.06

115

(3023199) Leukocytes [#/volume] in Pleural fluid

226

2.18

6.12

1.3

1.4

955.24

1981.65

e6/l

1.06

171

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

486

6022

0.78

6.11

1.2

1.3

11.27

15.29

u/ml

0.73

193

2172

(3018010) Neutrophils/100 leukocytes in Blood

1575

14203

1.19

6.10

5.2

5.6

59.24

57.17

7.56

1461

13046

(1175426) CD3 cells/100 lymphocytes in Blood

105

2.78

6.04

1.7

68.00

72.60

0.69

(3006504) Eosinophils/100 leukocytes in Blood

1552

13985

1.19

6.04

5.1

5.6

2.59

2.91

7.33

1442

12799

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3032

31469

0.81

5.82

4.5

4.7

1.54

1.61

mmol/l

13.64

2670

28378

(3035637) Corticotropin [Mass/volume] in Plasma

273

2.03

5.71

1.6

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

151

1007

1.52

5.56

1.4

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

962

8366

1.20

5.47

2.3

2.4

3.30

3.03

mg/l

2.45

815

7089

(3044242) Glucose [Moles/volume] in Arterial blood

124

2.51

5.36

3.3

2.1

—

(3022096) Basophils/100 leukocytes in Blood

1496

13536

1.17

5.34

5.2

5.6

0.65

0.70

3.75

1388

12357

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3067

31744

0.81

5.34

4.5

4.8

4.77

4.82

mmol/l

1.62

2716

28836

(3026726) Creatinine [Moles/volume] in Specimen

11.27

5.29

1.1

4.5

1953.78

260.88

umol/l

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

241

2.05

5.24

2.3

3.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

150

1013

1.50

5.23

1.3

1.2

—

(3021901) Oxygen saturation in Capillary blood

479

1.73

5.19

3.1

2.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1471

13331

1.17

5.08

3.9

33.02

78.38

ng/l

1.33

1127

9416

(3037756) Immunofixation for Serum or Plasma

103

644

1.62

5.05

1.5

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

111

709

1.58

4.99

2.5

2.1

125.91

127.26

g/l

0.26

512

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

522

6276

0.80

4.98

1.2

1.3

49.95

36.42

iu/ml

0.79

173

2067

(3022145) Colonoscopy Study observation

413

3313

1.28

4.98

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

402

3217

1.28

4.94

2.6

2.0

9.30

6.35

umol/l

1.35

341

2688

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

317

1.87

4.93

3.6

189.38

591.21

iu/ml

—

(3010421) pH of Blood

116

752

1.56

4.90

3.1

3.3

7.42

0.00

684

(3041096) Erythrocytes [Presence] in Urine by Automated

952

8344

1.19

4.89

4.9

4.0

—

(1616796) Gas panel - Central venous blood

601

1.61

4.71

2.8

3.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.59

4.63

1.8

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

604

1.60

4.62

3.0

2.5

15.87

16.13

0.25

306

(21494755) Public health laboratory ask at order entry panel

1352

0.62

4.61

1.3

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

435

3549

1.26

4.56

1.6

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

362

4485

0.79

4.49

1.3

519.39

594.82

titre

0.34

1112

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

119

800

1.50

4.30

2.4

3.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.04

4.23

1.9

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

220

1659

1.35

4.19

4.0

3.3

1.76

2.33

mmol/l

1.05

162

1273

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3442

33651

1.28

4.06

12.9

9.5

23.68

22.90

u/l

2.05

3319

31954

(3040151) Glucose [Moles/volume] in Capillary blood

354

1.74

4.03

4.6

6.5

7.62

7.15

mmol/l

0.43

295

(3009343) pH of Capillary blood

226

1723

1.33

4.02

4.0

3.3

7.43

7.42

0.19

234

(3017143) Hepatitis C virus Ab [Presence] in Serum

266

2075

1.30

4.01

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1113

0.61

4.01

1.6

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

158

1140

1.40

3.97

1.9

1.8

—

(3033799) Differential panel - Peritoneal fluid

3.26

3.90

1.1

2.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

378

3092

1.25

3.89

2.4

2.5

4.48

5.98

ug/l

1.83

317

2561

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

227

1745

1.32

3.82

4.1

3.3

5.26

5.25

kpa

0.11

212

1633

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

428

3558

1.23

3.80

1.6

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

283

2244

1.28

3.78

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1422

13081

1.14

3.65

2.7

2.8

152.53

103.03

ug/l

10.15

1282

11819

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.12

3.64

2.1

1.7

—

(3013512) EKG study

1145

10389

1.15

3.60

4.3

4.1

—

(3000012) Reticulocyte production index

390

1.65

3.58

1.9

1.8

—

(3012441) Differential panel - Pleural fluid

177

1.99

3.58

1.3

1.5

—

(3045788) Cell count panel - Pleural fluid

178

1.98

3.53

1.3

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

165

1226

1.36

3.51

1.9

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3177

32540

0.85

3.32

5.2

5.5

2.78

mmol/l

0.15

2805

29468

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

141

2.06

3.31

4.7

1.1

96.99

161.43

u/ml

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

241

1.79

3.26

2.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.78

3.25

1.1

2.6

1120.71

785.46

e6/l

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

837

9321

0.87

3.20

1.6

1.47

1.33

mmol/l

6.14

664

7708

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

229

1.80

3.15

1.4

1.3

37.08

43.98

u/l

0.61

160

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

201

1564

1.30

3.15

2.4

1.17

1.13

0.37

201

1555

(42529406) Shigella sp [Presence] in Stool by Culture

138

1016

1.37

3.15

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

111

2.17

3.12

1.3

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.44

3.10

1.0

1.1

—

(3035880) pH of Pleural fluid

2.29

3.09

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

137

1011

1.37

3.09

1.2

—

(3012501) Base excess in Blood by calculation

634

1.46

3.05

3.2

3.5

2.74

2.89

mmol/l

0.20

444

(3036481) Cortisol [Moles/volume] in Serum or Plasma

342

2846

1.22

3.04

2.5

1.7

400.47

373.43

nmol/l

1.53

313

2527

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1075

0.66

3.03

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

135

999

1.36

3.00

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

100

704

1.43

2.97

1.7

2.3

77.52

66.79

ug/min

0.15

394

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

507

1.51

2.96

1.2

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2951

30342

0.87

2.96

4.0

4.2

1.36

1.28

mmol/l

10.29

2570

26992

(3012516) Albumin [Mass/volume] in Urine

1118

10250

1.13

2.89

3.2

3.0

396.90

419.28

mg/l

0.05

680

5749

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

343

1.61

2.88

1.2

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2771

26797

1.13

2.75

22.4

15.5

15.32

15.38

0.23

2732

26198

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

232

1.73

2.75

1.2

1.1

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

8.34

2.75

1.2

58.80

337.17

umol/l

—

(3000492) Spirometry study

210

2608

0.79

2.72

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

1137

10472

1.12

2.70

3.1

3.0

6.28

6.04

mmol/l

1.37

937

8674

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

264

1.67

2.69

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

173

1351

1.29

2.69

6.8

6.9

24.51

24.82

mmol/l

0.60

165

1297

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

327

2747

1.21

2.67

2.1

36.30

37.69

u/l

0.12

267

2313

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

319

1.61

2.66

1.4

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

237

1927

1.25

2.65

1.6

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

351

1.58

2.64

1.5

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

587

1.44

2.63

1.9

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

104

1410

0.73

2.60

1.3

1.11

0.92

u/ml

0.08

138

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

355

4156

0.84

2.56

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

394

1.53

2.56

1.1

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

643

1.41

2.52

1.9

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

201

1.75

2.51

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

201

1.75

2.51

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

201

1.75

2.51

1.3

1.2

—

(4200892) Spirometry reversibility

215

2635

0.80

2.49

1.3

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1171

10845

1.12

2.49

3.8

3.6

7.95

7.68

mg/mmol

0.08

693

6081

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

656

7308

0.88

2.47

1.2

1.3

1.12

1.70

u/ml

1.21

178

1865

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

422

1.50

2.46

1.3

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

934

0.68

2.46

1.4

1.3

2.18

5.00

u/ml

—

119

(3044007) Cell count panel - Peritoneal fluid

2.67

2.45

1.2

2.6

—

(3010503) CD19 cells [#/volume] in Blood

2.14

2.44

2.5

2.0

0.12

0.23

e9/l

0.40

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1533

16249

0.90

2.39

2.3

2.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

220

1.69

2.37

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

6.26

2.37

1.6

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

137

1058

1.31

2.35

2.0

1.5

38.39

28.65

mg/l

1.02

106

849

(40768441) Liver Pathology biopsy report

132

1.90

2.35

1.0

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

502

1.44

2.32

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

946

0.69

2.32

1.4

1.3

24.10

5.48

u/ml

—

185

(3017354) Segmented neutrophils/100 leukocytes in Blood

237

1.65

2.31

2.3

2.5

63.38

60.39

0.35

195

(1761482) Bacteria [#/volume] in Urine by Culture

132

1017

1.31

2.31

4.4

5.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

137

1061

1.30

2.31

2.0

1.5

36.25

38.97

mg/l

0.44

107

857

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

170

1354

1.27

2.30

3.1

3.4

24.46

24.56

mmol/l

0.13

163

1326

(40765096) Chromosome analysis panel by Banding

3.22

2.30

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

259

2163

1.21

2.28

3.8

2.8

4.45

4.39

pmol/l

0.17

229

1856

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.56

2.27

1.4

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

157

1244

1.27

2.23

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

165

0.36

2.14

1.3

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

298

1.55

2.13

1.2

1.3

118.27

121.62

u/ml

0.11

(3007461) Platelets [#/volume] in Blood

3511

34652

1.20

2.10

29.3

19.9

260.05

258.45

e9/l

0.69

3427

33493

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

237

0.42

2.10

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

821

0.69

2.09

1.2

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

430

1.45

2.09

2.4

2.6

35.75

32.35

umol/l

0.36

381

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

282

3303

0.84

2.08

2.6

3.1

188.22

201.25

ng/l

0.23

254

3010

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.00

2.07

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.00

2.07

1.0

1.5

—

(3035941) MCH [Entitic mass]

3511

34661

1.20

2.04

29.2

19.8

30.07

30.19

3.71

3469

33962

(3024731) MCV [Entitic volume]

3511

34661

1.20

2.04

29.2

19.8

91.30

91.31

0.07

3470

33964

(3009542) Hematocrit [Volume Fraction] of Blood

3508

34630

1.20

2.03

29.2

19.8

38.08

39.11

18.19

3298

31712

(3010813) Leukocytes [#/volume] in Blood

3511

34663

1.20

2.02

29.3

19.9

6.70

6.58

e9/l

2.54

3421

33347

(3026361) Erythrocytes [#/volume] in Blood

3511

34665

1.20

2.01

29.4

19.9

4.26

4.38

e12/l

37.22

3419

33342

(36660697) Celiac disease serology panel - Serum

224

2667

0.83

1.99

1.1

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

3511

34670

1.20

1.97

29.6

20.0

127.06

131.61

g/l

71.23

3473

33977

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.34

1.96

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

735

1.33

1.96

3.7

3.8

29.32

23.87

mg/l

0.70

468

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

539

1.38

1.92

3.0

3.4

60.03

57.76

0.82

539

(40760888) Immunoglobulin light chains.free panel - Serum

101

772

1.32

1.92

2.0

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

413

1.44

1.92

1.4

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

165

1342

1.24

1.92

1.9

1.6

1.72

1.62

g/l

0.47

124

1152

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

113

1.86

1.91

2.0

2.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

130

1029

1.27

1.91

2.0

1.5

1.39

1.42

ratio

—

(3017569) Oxygen content in Arterial blood

135

1.78

1.91

3.5

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

365

1.46

1.88

1.4

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

365

1.46

1.88

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

265

0.49

1.86

1.8

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.65

1.86

1.8

1.4

46.08

42.84

pmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

135

1679

0.80

1.85

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

358

1.46

1.85

1.4

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

869

0.72

1.84

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

941

8744

1.10

1.81

1.5

22.11

21.91

nmol/l

0.12

805

7234

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

546

1.36

1.80

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

559

1.35

1.72

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

525

1.36

1.72

1.4

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.85

1.71

1.2

1.0

—

(3037121) Protein [Mass/volume] in Urine

128

1028

1.25

1.70

3.3

2.3

0.32

0.35

g/l

0.13

257

(3045142) Bone marrow Pathology biopsy report

188

1.60

1.65

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1032

0.76

1.64

1.5

1.7

—

(3022313) Gas panel - Capillary blood

148

1214

1.23

1.63

4.1

3.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

150

1.67

1.63

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

150

1.67

1.63

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

734

0.72

1.62

1.5

1.2

51.49

46.08

u/ml

—

100

(3026493) Urate [Moles/volume] in Serum or Plasma

844

7849

1.10

1.59

2.5

2.2

4935.77

5915.83

umol/l

0.23

696

6580

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

743

1.29

1.58

1.2

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.00

1.58

1.0

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

322

1.43

1.55

1.1

1.2

295.80

292.00

u/ml

0.03

196

(3010144) Erythrocytes [#/volume] in Synovial fluid

339

1.42

1.54

1.5

1.4

15450.00

160013.22

e6/l

2.94

220

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

475

1.35

1.54

1.2

—

nmol/l

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

122

1.73

1.54

1.1

—

2.29

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.03

1.54

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

907

0.76

1.52

1.5

1.6

4.40

3.68

mg/l

0.26

683

(40762365) Oxygen content in Arterial blood by calculation

2.60

1.51

1.6

2.8

15.27

14.63

ml/dl

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

250

1.48

1.49

1.5

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

250

1.48

1.49

1.5

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

307

0.58

1.49

1.1

1.0

1.47

1.63

u/ml

—

141

(3004616) Nuclear Ab [Presence] in Serum

465

0.66

1.49

1.3

—

(3008898) HLA-B27 [Presence]

834

0.75

1.47

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

190

2222

0.85

1.45

1.5

1.42

1.40

0.26

162

1904

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

102

1.77

1.44

1.3

1.1

—

(3019977) pH of Arterial blood

148

1.63

1.44

4.1

2.6

7.42

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

422

1.36

1.42

1.2

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

605

1.30

1.41

2.5

2.7

1.61

1.67

mg/l

0.24

537

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

677

1.28

1.39

2.2

2.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

338

1.40

1.39

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

408

4510

0.89

1.38

4.5

4.9

33.11

34.11

1.01

239

2912

(3025941) Bacteria identified in Stool by Culture

206

1775

1.17

1.38

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

416

1.35

1.37

1.2

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

416

1.35

1.37

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

299

0.60

1.37

1.2

1.1

0.62

0.86

u/ml

—

120

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

153

1286

1.20

1.37

1.2

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

2.61

1.36

1.2

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.94

1.36

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.94

1.36

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

307

1.41

1.34

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

124

1025

1.22

1.32

1.9

2.2

882.93

830.98

ug/l

0.04

117

950

(46235355) HIV 1 and 2 tests - Meaningful Use set

276

2439

1.14

1.32

1.4

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

131

1089

1.21

1.32

4.0

3.6

24.62

25.40

mmol/l

1.76

118

969

(3005988) Vibrio sp identified in Specimen by Organism specific culture

419

1.34

1.32

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

166

1412

1.18

1.31

1.5

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.10

1.30

1.8

2.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

429

1.33

1.30

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

483

1.31

1.27

1.3

262.99

224.61

miu/ml

0.25

213

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

365

0.66

1.27

1.3

1.1

0.45

1.26

u/ml

—

192

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.40

1.24

10.8

12.4

3.90

4.24

mmol/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.86

1.23

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

139

1.59

1.23

1.6

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.77

1.22

2.1

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.77

1.22

2.1

2.4

—

(3032057) Clostridioides difficile [Presence] in Stool

1.77

1.22

2.5

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

541

5851

0.91

1.22

1.3

2.41

2.37

g/l

0.21

289

3090

(3010726) Horse dander IgE Ab [Units/volume] in Serum

252

0.59

1.21

1.1

1.0

1.80

1.13

u/ml

—

131

(1002224) Polysomnography panel

874

0.79

1.20

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

173

1.51

1.17

1.2

1.6

9.60

9.56

umol/l

0.00

118

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

128

0.47

1.16

1.2

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

786

1.23

1.16

2.9

3.1

1.67

1.59

mmol/l

0.44

770

(40768443) Skin Pathology biopsy report

161

1384

1.17

1.15

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

145

1695

0.85

1.15

1.8

1.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.05

1.15

1.1

1.6

33.15

21.70

g/l

—

(3021788) Differential panel - Synovial fluid

667

0.76

1.15

1.6

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

131

1544

0.84

1.15

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

439

1.30

1.14

1.2

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

283

0.63

1.13

4.1

3.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

388

1.32

1.11

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

186

2125

0.87

1.10

2.4

17.07

29.12

au/ml

1.90

129

(3013139) Helicobacter pylori Ag [Presence] in Stool

223

2516

0.88

1.10

1.1

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.38

1.09

1.6

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

862

8152

1.07

1.09

1.7

26608657.75

30648608.48

pmol/l

0.08

684

6480

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

163

0.55

1.08

1.0

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

882

0.80

1.07

1.5

0.00

0.13

iu/ml

1.65

200

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

161

1.49

1.06

1.4

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

228

1.41

1.05

1.3

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

636

6778

0.93

1.03

3.7

4.0

128.50

246.56

ng/l

1.60

499

5473

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.74

1.02

1.2

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

114

964

1.19

1.02

1.4

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

107

0.47

1.01

1.0

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

261

2350

1.12

0.98

1.7

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.18

0.98

1.2

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.18

0.98

1.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

160

0.56

0.98

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

232

1.38

0.97

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

979

0.82

0.97

2.5

2.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

177

1557

1.14

0.97

1.5

1.09

1.25

g/l

1.43

160

1397

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

659

1.22

0.95

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

659

1.22

0.95

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

225

1.38

0.94

1.3

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

351

0.71

0.93

1.2

1.5

—

25.56

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

385

0.73

0.92

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.82

0.92

2.3

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3072

31099

0.93

0.91

5.6

2.97

2.03

mu/l

0.52

2752

28199

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

322

1.31

0.91

2.8

2.5

4.33

2.87

u/field

0.42

110

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

291

0.69

0.91

1.4

1.3

—

549.67

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

266

0.68

0.89

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

351

1.29

0.87

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.00

0.87

2.7

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

171

1924

0.88

0.86

1.2

1.3

41.17

50.74

au/ml

—

110

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

213

1.36

0.84

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

400

0.75

0.83

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

115

994

1.16

0.83

3.6

3.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

579

0.79

0.83

1.1

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

623

0.80

0.83

1.4

6.61

21.07

e6/l

1.43

482

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

238

0.67

0.83

1.0

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

354

1.27

0.82

1.1

134.17

121.23

1.23

315

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

754

0.82

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.74

0.82

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.69

0.82

1.0

1.1

—

(4034850) Laboratory test

136

1192

1.15

0.82

13.2

10.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

118

1024

1.16

0.81

3.5

3.4

0.76

0.83

nmol/l

1.02

811

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

237

0.67

0.81

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

237

0.67

0.81

1.0

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

318

0.72

0.81

1.1

1.2

—

68.10

—

(4146454) Self-monitoring of blood glucose

391

1.26

0.81

2.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

839

1.17

0.80

1.5

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

329

0.73

0.80

1.1

1.2

—

69.14

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

236

0.68

0.80

1.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

236

0.68

0.80

1.0

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.79

0.0

2.1

—

1.82

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

148

0.61

0.79

1.1

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

235

0.68

0.79

1.0

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

164

1837

0.89

0.78

1.3

137.56

172.41

u/ml

0.67

153

1680

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

225

1.34

0.78

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

182

1.38

0.77

2.0

2.3

2.95

2.91

u/field

0.01

115

(3003181) Sodium [Moles/volume] in Urine

732

1.18

0.77

1.3

57.57

61.37

mmol/l

0.42

589

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

235

1.32

0.75

1.3

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

302

0.73

0.75

1.1

—

0.87

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3033

30669

0.94

0.75

6.6

6.2

41.44

40.18

mmol/mol

10.73

2742

27908

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.60

0.74

1.1

—

(3042631) Mycobacterium sp identified in Specimen

333

1.26

0.74

1.8

3.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

220

0.68

0.74

1.1

1.0

2.83

2.77

u/ml

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

231

0.69

0.73

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

136

0.59

0.72

1.1

1.2

130.00

137.79

mmol/24h

—

136

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

401

0.77

0.72

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

1.52

0.72

1.4

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

326

1.26

0.71

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

344

1.25

0.71

2.8

3.2

—

(4212803) Bone marrow aspirate examination

1.92

0.70

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

217

0.69

0.70

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.71

0.70

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

373

1.24

0.69

1.2

5.19

3.55

u/ml

0.21

108

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

705

0.83

0.69

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3171

31999

0.94

0.68

5.2

5.0

6.20

5.95

mmol/l

18.38

2798

28706

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

144

1.39

0.67

1.1

1.08

1.07

ratio

—

(3034426) Prothrombin time (PT)

1.51

0.66

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

479

1.19

0.62

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

718

0.85

0.62

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

199

2170

0.91

0.62

2.4

2.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.67

0.61

1.0

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.61

2.4

2.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.60

0.61

1.0

143.75

114.06

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.01

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

140

0.64

0.60

1.3

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

367

0.79

0.60

1.3

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

122

1.40

0.60

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

122

1.40

0.60

1.4

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1119

0.88

0.59

1.6

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.59

0.0

1.0

—

(3016038) Potassium [Moles/volume] in Urine

272

1.25

0.59

1.0

1.1

34.93

33.64

mmol/l

0.13

217

(44813793) Dust mix specific IgE antibody measurement

209

0.72

0.59

1.0

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2672

27050

0.96

0.59

4.8

4.6

15.16

15.05

pmol/l

1.45

2396

24319

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

114

1276

0.89

0.59

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.58

0.0

1.1

—

(3017704) Immunofixation for Urine

175

1.32

0.58

1.6

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

123

1.38

0.57

1.4

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

123

1.38

0.57

1.0

5.1

89.00

63.13

mg/l

0.36

(3045424) Erythrocytes [Presence] in Urine

567

1.17

0.57

1.7

1.6

—

(3003338) MCHC [Mass/volume]

2598

25645

1.04

0.57

26.2

18.1

328.73

330.00

g/l

11.69

2571

25448

(3019309) Folate [Moles/volume] in Red Blood Cells

734

7628

0.95

0.56

1.8

1308.94

1199.20

nmol/l

2.04

542

5590

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

115

1.39

0.56

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

218

0.73

0.56

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.55

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.55

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.55

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.55

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

107

1.40

0.55

1.1

1.0

93.44

93.85

—

(3032773) Endomysium IgG Ab [Titer] in Serum

251

0.76

0.55

1.3

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

116

1.38

0.54

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

470

0.83

0.53

1.4

1.5

63.08

57.79

0.49

282

(3038515) Glucose [Moles/volume] in Venous blood

759

1.14

0.53

3.1

3.2

8.11

7.67

mmol/l

0.72

743

(3005719) IgG [Mass/volume] in Serum or Plasma

214

1984

1.08

0.53

2.5

2.4

10.15

10.49

g/l

0.66

192

1800

(3014891) Appearance of Pleural fluid

1.54

0.53

1.0

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

873

1.13

0.53

1.5

0.00

g/l

-0.00

791

(3051651) Icteric interference index of Serum or Plasma

134

1.34

0.53

3.1

3.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

143

1.33

0.52

1.2

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.45

0.51

2.6

2.0

458.33

765.79

e6/l

2.76

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.50

0.51

1.0

1.2

43.00

69.55

nmol/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

126

1.35

0.51

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

650

1.14

0.50

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

638

0.86

0.50

1.4

1.3

—

90.77

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

213

0.75

0.50

1.1

—

(21494434) Karyotype in Bone marrow

189

1.27

0.49

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

888

1.12

0.49

1.5

0.00

g/l

-0.00

793

(3023430) Cat dander IgE Ab [Units/volume] in Serum

201

0.75

0.49

1.1

2.62

2.74

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

334

0.81

0.48

1.1

3.62

3.48

u/ml

—

112

(3027135) IgG subclass 1 [Mass/volume] in Serum

271

1.22

0.48

1.1

1.5

7.07

6.82

g/l

0.14

184

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.52

0.48

1.0

—

81.40

—

(3044290) Cell count panel - Cerebral spinal fluid

581

0.86

0.47

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

102

919

1.11

0.47

1.6

1.7

5.54

4.72

iu/l

0.27

302

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.46

0.46

1.0

1.1

—

81.40

—

(3036180) Methadone [Presence] in Urine

1.43

0.46

1.0

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

0.61

0.45

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

255

1.22

0.45

2.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.40

0.45

3.3

3.4

0.43

0.80

u/field

—

(3016018) Differential panel - Cerebral spinal fluid

285

0.81

0.43

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

945

0.90

0.43

1.5

1.7

0.26

0.23

g/l

2.04

891

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.61

0.43

2.4

2.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.43

0.42

1.3

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

262

0.80

0.42

1.0

1.1

—

68.92

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.38

0.42

1.1

1.5

3.68

2.27

umol/l

0.72

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.40

0.42

1.4

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

149

1.28

0.41

1.3

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.43

0.41

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.52

0.41

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.41

0.0

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.75

—

(3011985) Renin [Units/volume] in Plasma

482

1.14

0.41

1.2

1.3

43.87

46.59

mu/l

0.08

427

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

161

0.74

0.41

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.36

0.41

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.33

0.40

1.1

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

380

1.16

0.40

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

150

1.27

0.40

1.1

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.40

0.0

2.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

149

0.74

0.40

1.9

123.80

51.83

ug/l

0.67

144

(3048689) Calprotectin [Mass/mass] in Stool

371

3879

0.95

0.40

1.9

148.57

138.14

ug/g

0.15

278

2961

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

102

0.69

0.39

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

193

0.78

0.39

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

1.27

0.38

1.3

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

136

0.73

0.37

1.0

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

271

1.18

0.37

1.1

1.5

2.76

2.72

g/l

0.04

181

(3024139) IgG subclass 3 [Mass/volume] in Serum

271

1.18

0.37

1.1

1.5

0.50

0.38

g/l

0.43

185

(3024932) HLA-DR beta [Type]

1.35

0.37

1.2

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.29

0.36

1.3

—

(3000330) Specific gravity of Urine by Test strip

187

1986

0.94

0.36

4.0

—

(3028433) Virus identified in Specimen by Culture

1.33

0.35

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

323

3092

1.05

0.34

3.4

3.1

92.56

84.30

ng/l

1.02

258

2539

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

222

0.81

0.34

1.2

0.10

1.30

u/ml

—

122

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

156

0.77

0.34

1.2

1.1

—

(3004451) EKG impression Narrative

172

1.22

0.34

1.2

1.3

—

(3024263) Appearance of Synovial fluid

172

1.22

0.34

1.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1084

11060

0.97

0.33

2.3

2.1

206.91

189.94

u/l

0.16

1011

10201

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.30

0.33

3.2

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

592

0.89

0.32

1.6

1.4

—

(3023419) Bacteria identified in Sputum by Culture

455

0.88

0.32

2.5

2.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

201

1.20

0.32

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

936

0.92

0.32

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

956

0.92

0.31

1.5

1.6

1.27

1.19

g/l

1.93

898

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

351

1.14

0.31

1.1

1.63

700.12

iu/ml

—

(1761868) Lipid panel - Serum or Plasma

953

9331

1.03

0.31

3.4

3.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

352

1.14

0.31

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

208

2187

0.95

0.30

1.2

115.45

141.87

iu/ml

0.63

834

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

129

1.24

0.30

2.9

4.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.29

0.30

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

448

1.12

0.29

1.7

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

239

0.84

0.29

1.1

—

(3006462) Nitrate [Presence] in Urine

174

0.80

0.29

4.9

4.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

130

0.77

0.29

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

482

0.89

0.29

1.3

—

(3020491) Glucose [Moles/volume] in Blood

214

1.17

0.27

2.1

2.3

7.95

7.05

mmol/l

0.60

137

(3016244) Insulin [Units/volume] in Serum or Plasma

116

0.78

0.27

3.4

2.8

37.27

21.94

mu/l

—

111

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

252

1.15

0.27

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

375

1.12

0.27

1.2

2.64

4.36

u/ml

0.98

151

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

101

945

1.07

0.25

1.5

1.4

0.01

g/l

0.03

847

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

169

1.18

0.25

1.4

1.3

0.23

0.29

nmol/l

0.47

119

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

117

1101

1.06

0.25

1.5

0.43

0.35

g/l

0.19

910

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

127

0.79

0.25

1.3

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

170

0.82

0.25

1.3

1.9

15.57

16.63

nmol/l

0.38

151

(3051101) Glucose [Moles/volume] in Cord blood

1.18

0.24

8.7

5.9

—

(3027944) Amphetamines [Presence] in Urine

265

1.13

0.23

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

218

1.15

0.23

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.32

0.23

1.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.32

0.23

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.32

0.23

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

327

3168

1.04

0.23

1.5

1.6

—

(3024471) HLA-A [Type]

1.28

0.23

1.0

—

(3011648) Oxygen content in Venous blood

228

1.14

0.22

1.5

2.0

9.03

10.87

1.62

228

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.25

0.22

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.25

0.22

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.74

0.22

1.0

1.4

108.71

87.89

ng/l

—

(3028707) Methadone [Presence] in Urine by Screen method

144

1.18

0.22

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.19

0.21

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.19

0.21

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

3.0

—

1.26

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.9

—

332.10

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.21

0.0

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

217.00

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

750.60

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.62

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1541

15572

0.98

0.21

2.3

79.76

81.33

nmol/l

1.44

1356

13539

(3024869) Neuronal Ab [Presence] in Serum

1.16

0.21

1.2

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

126

1.19

0.21

1.0

1.1

1.12

1.04

u/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.05

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.04

—

(3017732) Neutrophils [#/volume] in Blood

222

2143

1.04

0.20

3.4

3.0

8.21

4.85

e9/l

0.92

159

1609

(3006653) Thiamine [Moles/volume] in Blood

127

1.18

0.19

1.4

1.3

145.47

133.96

nmol/l

0.41

127

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

122

0.82

0.19

1.0

1.8

265.10

209.78

u/l

—

122

(3000764) Benzodiazepines [Presence] in Urine

270

1.11

0.18

1.2

—

(3028300) Cannabinoids [Presence] in Urine

270

1.11

0.18

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.24

0.18

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.24

0.18

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

347

1.10

0.18

1.0

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

415

1.09

0.18

1.1

1.6

0.53

0.68

g/l

0.91

304

(40768797) Stomach Pathology biopsy report

472

4816

0.98

0.17

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.13

0.17

1.0

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.13

0.17

1.0

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

205

1.12

0.17

1.3

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

129

1.16

0.17

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

361

0.91

0.17

1.1

1.0

—

(3044941) Cell count panel - Synovial fluid

557

0.93

0.16

1.8

1.4

—

(3006270) Folate [Moles/volume] in Blood

340

0.91

0.16

1.0

1.2

342.04

348.62

nmol/l

0.07

269

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

101

1.19

0.16

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

246

0.89

0.16

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1239

1.04

0.16

1.4

10.08

9.93

g/l

0.13

109

1049

(3011288) Drugs identified in Urine by Screen method

177

1.13

0.16

1.3

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

109

1043

1.05

0.16

1.5

1.4

36.83

37.42

g/l

0.53

862

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

130

0.85

0.16

3.6

1.7

288.00

135.21

umol/l

—

(3020650) Glucose [Presence] in Urine

1.10

0.15

1.1

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

130

1.15

0.15

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

245

0.90

0.15

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

119

0.84

0.15

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.14

0.15

1.3

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.13

0.15

1.7

1.8

—

(3015183) Erythrocyte sedimentation rate

0.81

0.14

1.3

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

285

1.09

0.14

1.9

1.8

1.06

0.94

g/24h

0.15

120

(3024928) Oxygen saturation in Venous blood

626

1.06

0.14

2.2

2.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.19

0.14

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

470

1.06

0.14

2.4

2.2

—

(3019225) pH of Specimen

372

3650

1.02

0.13

4.4

3.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

100

0.80

0.13

1.0

1.1

1672.50

1744.42

miu/ml

—

100

(3020717) Zinc [Moles/volume] in Serum or Plasma

151

1.13

0.13

1.6

1.3

29.62

22.56

umol/l

0.37

141

(3027008) Opiates [Presence] in Urine

267

1.09

0.13

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

142

1.13

0.12

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

171

1.11

0.12

14.7

10.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

473

1.06

0.12

2.1

35.56

27.85

mg/l

0.33

116

(3000034) Microalbumin [Mass/volume] in Urine

323

0.93

0.12

3.7

2.8

45.60

18.29

mg/l

0.46

223

(3045414) Leukocytes [Presence] in Urine

158

1623

0.97

0.11

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

126

0.87

0.11

1.1

1.2

—

(3000494) Fungus identified in Specimen by Culture

363

3574

1.02

0.10

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

106

1.13

0.09

1.0

1.1

18.20

286.03

ng/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.09

0.09

5.0

7.9

—

(3016879) Cocaine [Presence] in Urine

252

1.07

0.09

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

145

1.10

0.09

2.4

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

458

1.05

0.09

1.2

85.06

25.92

u/l

0.43

392

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

184

1.09

0.09

1.0

1.1

7.47

12.25

iu/ml

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.11

0.09

1.7

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

134

0.90

0.08

1.1

—

7.92

—

(3007916) DNA double strand Ab [Titer] in Serum

0.83

0.08

1.0

1.3

—

126.98

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

108

1052

1.03

0.08

1.5

1.4

252.97

293.93

ug/g

1.17

614

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

117

1.11

0.08

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2491

24977

0.99

0.08

4.1

4.5

18.17

13.74

mm/h

26.80

2237

22868

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.12

0.07

1.3

1.4

24.33

29.12

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.82

0.07

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.81

0.07

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.80

0.07

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.80

0.07

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

767

1.03

0.07

2.1

2.0

11.22

11.61

mg/l

0.19

698

(3029075) Extractable nuclear Ab panel - Serum

1.05

0.07

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

143

0.91

0.07

1.2

1.4

1.66

1.65

g/l

0.06

143

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.87

0.07

1.3

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.87

0.06

1.4

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

125

1225

1.02

0.06

1.5

1.4

3.21

2.99

g/l

1.15

107

1045

(3020911) Cortisol [Moles/time] in 24 hour Urine

101

0.89

0.06

1.1

1.4

76.89

62.45

nmol/24h

—

101

(3006442) Creatine [Moles/volume] in Serum or Plasma

187

1.07

0.06

1.5

1.7

72.25

77.93

umol/l

0.58

187

(21494890) Protein electrophoresis panel - 24 hour Urine

264

0.95

0.06

1.4

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

724

1.02

0.04

1.7

1.9

4.61

4.88

mmol/24h

0.24

613

(3007566) Smooth muscle Ab [Titer] in Serum

794

1.02

0.04

1.1

1.2

80.00

183.97

titre

—

(3014271) Vancomycin [Susceptibility]

221

0.95

0.04

2.6

3.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

685

0.98

0.04

1.3

39.02

39.55

iu/l

0.04

603

(3035320) C reactive protein [Mass/volume] in Body fluid

220

1.05

0.03

2.3

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

149

0.94

0.03

1.6

1.7

—

(4062490) Immunoglobulin typing, IgG

270

1.04

0.03

1.1

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1561

15583

1.00

0.02

2.1

96.21

98.97

pmol/l

1.27

773

6993

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

331

1.03

0.02

1.4

1.5

28.91

35.91

0.63

197

(3004775) Volume in Urine collected for unspecified duration

232

1.03

0.02

1.8

2.4

719.31

610.84

0.83

164

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

123

1.06

0.01

2.1

2.3

—

(3044927) Protein electrophoresis panel - Urine

402

1.02

0.01

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

528

0.98

0.01

1.3

1.5

0.93

0.75

nmol/l

0.86

431

(3000475) Leukocytes [#/volume] in Synovial fluid

892

1.01

0.01

1.7

1.6

16711.89

12306.17

e6/l

0.29

631

(3024666) Lithium [Moles/volume] in Serum or Plasma

1.06

0.01

7.8

11.1

0.71

0.66

mmol/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

284

1.02

0.00

1.3

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

1.03

0.00

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

163

0.98

0.00

2.3

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

146

1.03

0.00

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

337

1.01

0.00

1.3

1.5

273.36

272.46

mosm/kgh2o

0.07

254

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1319

1.00

0.00

1.5

1.4

8.01

7.68

g/l

1.13

114

1140

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1315

1.00

0.00

1.5

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

106

1.04

0.00

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

512

1.00

0.00

1.4

—

(3022621) pH of Urine by Test strip

242

2421

1.00

0.00

3.4

3.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

125

1246

1.00

0.00

2.1

2.0

36.66

40.22

u/l

1.16

114

1074

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

153

0.98

0.00

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

1316

1.00

0.00

1.5

1.4

3.89

3.67

g/l

0.96

114

1138

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

169

1.01

0.00

2.5

2.3

—

(3022689) Creatine [Moles/volume] in Urine

1.03

0.00

1.6

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

120

1.00

0.00

1.4

1.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

110

1.00

0.00

1.9

2.3

38546.26

37970.68

ug/l

0.04

110

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

291.13

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1106.25

—

(3052592) Norovirus Ag [Presence] in Stool

1.01

-0.00

1.7

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40768446) Kidney Pathology biopsy report

0.91

-0.00

1.3

1.4

—

(3048879) Bone marrow aspiration report

0.88

-0.00

1.2

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

4.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.96

-0.00

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.01

-0.00

3.0

2.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.00

-0.00

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

23.55

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.00

-0.00

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

1.34

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.96

-0.00

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.95

-0.00

1.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.91

-0.00

1.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_CORPUS_UTERI_WIDE – Malignant neoplasm of corpus uteri, including Hilmo

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of corpus uteri, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of corpus uteri, including Hilmo (C3_CORPUS_UTERI_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints